Benson, A. B., Maitra, A., Javle, M., Overman, M., Davis, R. E., Vats, P., . . . Neelapu, S. Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer. BMJ Publishing Group.
Chicago Style (17th ed.) CitationBenson, Al B., et al. Randomized Phase II Study of the Bruton Tyrosine Kinase Inhibitor Acalabrutinib, Alone or with Pembrolizumab in Patients with Advanced Pancreatic Cancer. BMJ Publishing Group.
MLA (9th ed.) CitationBenson, Al B., et al. Randomized Phase II Study of the Bruton Tyrosine Kinase Inhibitor Acalabrutinib, Alone or with Pembrolizumab in Patients with Advanced Pancreatic Cancer. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.